These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35034646)
41. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212 [TBL] [Abstract][Full Text] [Related]
42. Development of a New Index Based on Preoperative Serum Lipocalin 2 to Predict Post-LSG Weight Reduction. Li N; Xu B; Zeng J; Lei S; Gu L; Feng L; Zhu B; Huang Y; Wang L; Su L; Qu S; Cheng X; Bu L Obes Surg; 2022 Apr; 32(4):1184-1192. PubMed ID: 35138515 [TBL] [Abstract][Full Text] [Related]
43. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score. Yeo SC; Ong WM; Cheng KSA; Tan CH Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812 [TBL] [Abstract][Full Text] [Related]
45. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy. Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259 [TBL] [Abstract][Full Text] [Related]
46. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis. Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358 [TBL] [Abstract][Full Text] [Related]
47. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. Abdelbary MS; Marzaban R; Gamal Eldeen H; Khairy M; Menesy M; Fahmy MH; Ayad AM; Mouheb BS; Yosry A Rev Gastroenterol Mex (Engl Ed); 2021; 86(2):125-132. PubMed ID: 33004251 [TBL] [Abstract][Full Text] [Related]
48. Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study. Wan T; Köhn N; Kröll D; Berzigotti A Obes Surg; 2021 Feb; 31(2):702-711. PubMed ID: 32959331 [TBL] [Abstract][Full Text] [Related]
49. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. Argentou M; Tiniakos DG; Karanikolas M; Melachrinou M; Makri MG; Kittas C; Kalfarentzos F Obes Surg; 2009 Sep; 19(9):1313-23. PubMed ID: 19693638 [TBL] [Abstract][Full Text] [Related]
50. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery. Yuan X; Chen J; Cheng Q; Zhao Y; Zhang P; Shao X; Bi Y; Shi X; Ding Y; Sun X; Xue B BMC Gastroenterol; 2018 Oct; 18(1):147. PubMed ID: 30285651 [TBL] [Abstract][Full Text] [Related]
51. Preliminary Evaluation of Acoustic Radiation Force Impulse Shear Wave Imaging to Detect Hepatic Fibrosis in Morbidly Obese Patients Before Bariatric Surgery. Praveenraj P; Gomes RM; Basuraju S; Kumar S; Senthilnathan P; Parathasarathi R; Rajapandian S; Palanivelu C J Laparoendosc Adv Surg Tech A; 2016 Mar; 26(3):192-5. PubMed ID: 26895403 [TBL] [Abstract][Full Text] [Related]
52. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Lautenbach A; Wernecke M; Mann O; Wagner J; Wolter S; Stoll F; Aberle J Obes Surg; 2023 Feb; 33(2):530-538. PubMed ID: 36508157 [TBL] [Abstract][Full Text] [Related]
53. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. Parente DB; Perazzo H; Paiva FF; Campos CFF; Saboya CJ; Pereira SE; Silva FDE; Rodrigues RS; Perez RM Sci Rep; 2020 Sep; 10(1):15007. PubMed ID: 32929103 [TBL] [Abstract][Full Text] [Related]
54. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity. Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916 [TBL] [Abstract][Full Text] [Related]
55. Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity. López López AP; Tuli S; Lauze M; Becetti I; Pedreira CC; Huber FA; Omeroglu E; Singhal V; Misra M; Bredella MA J Clin Endocrinol Metab; 2023 Nov; 108(12):e1489-e1495. PubMed ID: 37403207 [TBL] [Abstract][Full Text] [Related]